6-Aminohexanoic Acid Latest Market Analysis Report 2025
On Oct 24, the latest report "Global 6-Aminohexanoic Acid Market 2025 by Manufacturers, Regions, Types and Applications, Forecast to 2031" from Global Info Research provides a detailed and comprehensive analysis of the global 6-Aminohexanoic Acid market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2025.
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/2740837/6-aminohexanoic-acid
According to our (Global Info Research) latest study, the global 6-Aminohexanoic Acid market size was valued at US$ 68.2 million in 2024 and is forecast to a readjusted size of USD 83.6 million by 2031 with a CAGR of 2.8% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
6‑Aminohexanoic acid (also known as ε‑aminocaproic acid) is a linear ε‑amino acid used both as an Active Pharmaceutical Ingredient (API) and a chemical intermediate. Structurally similar to lysine, it acts as a plasmin inhibitor, making it the key raw material for manufacturing antifibrinolytic drugs such as aminocaproic acid injections and tablets. Additionally, it serves as a crucial intermediate in the synthesis of nylon‑6, typically produced by hydrolyzing caprolactam. As an API, rigorous quality requirements must be met, including high purity, low ash content, minimal heavy metals, and absence of toxic by‑products, to ensure the safety and efficacy of final dosage forms.
6-Aminohexanoic acid is primarily used as an active pharmaceutical ingredient (API) intermediate for aminocaproic acid formulations, such as injectable and oral antifibrinolytic drugs. Demand for this compound is relatively inelastic due to the sustained clinical use of aminocaproic acid in surgical, urological, obstetric, and hematologic applications. The global supply is mainly concentrated in countries like China and India, where manufacturers focus heavily on export markets. Additionally, this compound has limited industrial use in polymer chemistry, particularly in the production of nylon-6. Increasingly stringent pharmacopoeial standards worldwide are placing greater regulatory and technical demands on producers.As surgical procedures become more prevalent globally and the emphasis on perioperative blood management intensifies—particularly with aging populations—the demand for aminocaproic acid formulations is expected to grow steadily, thus ensuring stable consumption of its upstream raw material, 6-aminohexanoic acid. Emerging healthcare systems in developing countries will contribute to incremental market growth. Technological upgrades driven by continuous processing, green chemistry, and automation will enhance production efficiency and sustainability. Furthermore, rising international compliance expectations, coupled with the advancement of generic drug equivalency programs, will favor well-regulated and high-capacity producers in global markets.The core drivers of the 6-aminohexanoic acid market include stable downstream pharmaceutical demand, enhanced focus on transfusion management, improved drug accessibility in developing nations, and stricter regulatory harmonization. However, challenges persist. As a mature molecule with relatively low technical barriers, the market faces intense competition and volatile pricing. In some advanced markets, newer antifibrinolytic agents are gradually replacing traditional therapies, introducing substitution risks. Meanwhile, increasingly rigorous environmental and GMP regulations, as well as the high cost of international certifications, pose significant barriers to smaller or non-compliant manufacturers. The industry is likely to consolidate around large, compliant, and environmentally sustainable producers.
This report is a detailed and comprehensive analysis for global 6-Aminohexanoic Acid market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
6-Aminohexanoic Acid market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Pharmaceutical Grade、 Industrial Grade、 Others
Market segment by Application: Pharmaceutical、 Polymer、 Others
Major players covered: Biophore、 Dipharma、 Optimus Pharma、 MSN Laboratories、 Sekisui Medical、 Sunny Pharmtech、 Hunan Er-Kang Pharmaceutical、 Changzhou Lanling Pharmaceutical、 Jiangsu Yongan Pharmceutical、 Sichuan Renan Pharmaceutical
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 6-Aminohexanoic Acid product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of 6-Aminohexanoic Acid, with price, sales quantity, revenue, and global market share of 6-Aminohexanoic Acid from 2020 to 2025.
Chapter 3, the 6-Aminohexanoic Acid competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 6-Aminohexanoic Acid breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment 6-Aminohexanoic Acid the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the 6-Aminohexanoic Acid sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2024.and 6-Aminohexanoic Acid market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of 6-Aminohexanoic Acid.
Chapter 14 and 15, to describe 6-Aminohexanoic Acid sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for 6-Aminohexanoic Acid
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/2740837/6-aminohexanoic-acid
According to our (Global Info Research) latest study, the global 6-Aminohexanoic Acid market size was valued at US$ 68.2 million in 2024 and is forecast to a readjusted size of USD 83.6 million by 2031 with a CAGR of 2.8% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
6‑Aminohexanoic acid (also known as ε‑aminocaproic acid) is a linear ε‑amino acid used both as an Active Pharmaceutical Ingredient (API) and a chemical intermediate. Structurally similar to lysine, it acts as a plasmin inhibitor, making it the key raw material for manufacturing antifibrinolytic drugs such as aminocaproic acid injections and tablets. Additionally, it serves as a crucial intermediate in the synthesis of nylon‑6, typically produced by hydrolyzing caprolactam. As an API, rigorous quality requirements must be met, including high purity, low ash content, minimal heavy metals, and absence of toxic by‑products, to ensure the safety and efficacy of final dosage forms.
6-Aminohexanoic acid is primarily used as an active pharmaceutical ingredient (API) intermediate for aminocaproic acid formulations, such as injectable and oral antifibrinolytic drugs. Demand for this compound is relatively inelastic due to the sustained clinical use of aminocaproic acid in surgical, urological, obstetric, and hematologic applications. The global supply is mainly concentrated in countries like China and India, where manufacturers focus heavily on export markets. Additionally, this compound has limited industrial use in polymer chemistry, particularly in the production of nylon-6. Increasingly stringent pharmacopoeial standards worldwide are placing greater regulatory and technical demands on producers.As surgical procedures become more prevalent globally and the emphasis on perioperative blood management intensifies—particularly with aging populations—the demand for aminocaproic acid formulations is expected to grow steadily, thus ensuring stable consumption of its upstream raw material, 6-aminohexanoic acid. Emerging healthcare systems in developing countries will contribute to incremental market growth. Technological upgrades driven by continuous processing, green chemistry, and automation will enhance production efficiency and sustainability. Furthermore, rising international compliance expectations, coupled with the advancement of generic drug equivalency programs, will favor well-regulated and high-capacity producers in global markets.The core drivers of the 6-aminohexanoic acid market include stable downstream pharmaceutical demand, enhanced focus on transfusion management, improved drug accessibility in developing nations, and stricter regulatory harmonization. However, challenges persist. As a mature molecule with relatively low technical barriers, the market faces intense competition and volatile pricing. In some advanced markets, newer antifibrinolytic agents are gradually replacing traditional therapies, introducing substitution risks. Meanwhile, increasingly rigorous environmental and GMP regulations, as well as the high cost of international certifications, pose significant barriers to smaller or non-compliant manufacturers. The industry is likely to consolidate around large, compliant, and environmentally sustainable producers.
This report is a detailed and comprehensive analysis for global 6-Aminohexanoic Acid market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
6-Aminohexanoic Acid market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Pharmaceutical Grade、 Industrial Grade、 Others
Market segment by Application: Pharmaceutical、 Polymer、 Others
Major players covered: Biophore、 Dipharma、 Optimus Pharma、 MSN Laboratories、 Sekisui Medical、 Sunny Pharmtech、 Hunan Er-Kang Pharmaceutical、 Changzhou Lanling Pharmaceutical、 Jiangsu Yongan Pharmceutical、 Sichuan Renan Pharmaceutical
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 6-Aminohexanoic Acid product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of 6-Aminohexanoic Acid, with price, sales quantity, revenue, and global market share of 6-Aminohexanoic Acid from 2020 to 2025.
Chapter 3, the 6-Aminohexanoic Acid competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 6-Aminohexanoic Acid breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment 6-Aminohexanoic Acid the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the 6-Aminohexanoic Acid sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2024.and 6-Aminohexanoic Acid market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of 6-Aminohexanoic Acid.
Chapter 14 and 15, to describe 6-Aminohexanoic Acid sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for 6-Aminohexanoic Acid
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
